Clinical Trial Update: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura [Phase 4]

View source ↗

Summary

The Phase 4 trial of prophylactic plasma infusion therapy for congenital thrombotic thrombocytopenic purpura has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Thrombotic Thrombocytopenic Purpura
• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Fresh Frozen Plasma (fresh frozen plasma)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Purpura, Thrombotic Thrombocytopenic | Phase 4 | Status: WITHDRAWN